IN8BIO Files Definitive Proxy Statement
Ticker: INAB · Form: DEF 14A · Filed: Mar 17, 2025 · CIK: 1740279
| Field | Detail |
|---|---|
| Company | In8bio, Inc. (INAB) |
| Form Type | DEF 14A |
| Filed Date | Mar 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
IN8BIO proxy statement filed. Get ready to vote on exec pay & board.
AI Summary
IN8BIO, INC. filed its definitive proxy statement on March 17, 2025, for its annual meeting of stockholders. The filing, designated as DEF 14A, outlines the company's governance and proposals to be voted on by shareholders. Key details regarding executive compensation, director elections, and other corporate matters will be presented for shareholder approval.
Why It Matters
This filing is crucial for shareholders as it details the company's leadership, executive compensation, and key proposals that will shape the company's future direction and governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing, not indicating any immediate financial or operational risks.
Key Numbers
- 14 — Public Document Count (Indicates the number of documents included in the filing.)
Key Players & Entities
- IN8BIO, INC. (company) — Registrant
- 0001740279 (company) — Central Index Key
- Incysus Therapeutics, Inc. (company) — Former Company Name
- 20180510 (date) — Date of Name Change
- 20250317 (date) — Filing Date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information regarding the company's annual meeting of stockholders and the matters to be voted upon, including director elections and executive compensation.
When was this definitive proxy statement filed?
This definitive proxy statement was filed on March 17, 2025.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001740279.
What was IN8BIO, INC.'s former company name?
IN8BIO, INC.'s former company name was Incysus Therapeutics, Inc.
What is the fiscal year end for IN8BIO, INC.?
The fiscal year end for IN8BIO, INC. is December 31st (1231).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 17, 2025 regarding IN8BIO, INC. (INAB).